Michael Billock

NPI: 1962164046
Total Payments
$3,673
2024 Payments
$1,127
Companies
17
Transactions
164
Medicare Patients
528
Medicare Billing
$52,607

Payment Breakdown by Category

Food & Beverage$3,599 (98.0%)
Education$74.25 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,599 162 98.0%
Education $74.25 2 2.0%

Top Paying Companies

Company Total Records Latest Year
Neurocrine Biosciences, Inc. $722.38 14 $0 (2024)
Lundbeck LLC $517.59 35 $0 (2024)
Janssen Pharmaceuticals, Inc $412.54 16 $0 (2024)
Teva Pharmaceuticals USA, Inc. $347.30 26 $0 (2024)
ABBVIE INC. $346.83 17 $0 (2024)
ITI, Inc. $326.00 10 $0 (2023)
Otsuka America Pharmaceutical, Inc. $305.48 18 $0 (2024)
ACADIA Pharmaceuticals Inc $143.68 2 $0 (2024)
Alkermes, Inc. $119.30 3 $0 (2022)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $78.73 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,127 45 Janssen Pharmaceuticals, Inc ($277.17)
2023 $860.02 26 Neurocrine Biosciences, Inc. ($366.65)
2022 $1,386 82 Teva Pharmaceuticals USA, Inc. ($256.88)
2021 $300.36 11 Neurocrine Biosciences, Inc. ($143.59)

All Payment Transactions

164 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/04/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $25.26 General
Category: PARKINSONS DISEASE PSYCHOSIS
11/27/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $8.61 General
Category: PSYCHIATRY
11/21/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $17.52 General
Category: PSYCHIATRY
11/20/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $115.20 General
Category: Neuropsychiatry
11/11/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $118.42 General
Category: PARKINSONS DISEASE PSYCHOSIS
10/30/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $20.00 General
Category: PSYCHIATRY
10/30/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $2.50 General
Category: PSYCHIATRY
10/29/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $19.99 General
Category: Neurology
10/17/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $80.73 General
Category: Neuroscience
09/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.79 General
Category: PSYCHIATRY
08/21/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $22.22 General
Category: PSYCHIATRY
08/08/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $59.52 General
Category: PSYCHIATRY
08/07/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.71 General
Category: PSYCHIATRY
07/24/2024 Lundbeck LLC ABILIFY MAINTENA (Drug) Food and Beverage Cash or cash equivalent $14.94 General
Category: PSYCHIATRY
07/18/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $20.83 General
Category: PSYCHIATRY
07/10/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $12.50 General
Category: PSYCHIATRY
06/27/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $129.41 General
Category: Neuroscience
06/12/2024 Lundbeck LLC ABILIFY MAINTENA (Drug) Food and Beverage Cash or cash equivalent $20.94 General
Category: PSYCHIATRY
06/12/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.60 General
Category: PSYCHIATRY
06/11/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $16.74 General
Category: Neuroscience
05/29/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.63 General
Category: Central Nervous System
05/22/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $22.97 General
Category: PSYCHIATRY
05/15/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.34 General
Category: Neuropsychiatry
05/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $31.50 General
Category: NEUROSCIENCE
05/14/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $4.69 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 473 713 $83,791 $46,958
2022 2 55 110 $11,518 $5,649
Total Patients
528
Total Services
823
Medicare Billing
$52,607
Procedure Codes
8

All Medicare Procedures & Services

8 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 59 195 $26,106 $13,011 49.8%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 83 186 $21,788 $12,853 59.0%
90792 Psychiatric diagnostic evaluation with medical services Facility 2023 95 96 $18,379 $10,896 59.3%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 76 76 $14,550 $8,791 60.4%
90785 Psychiatric services complicated by communication factor Facility 2023 93 93 $1,725 $810.96 47.0%
90785 Psychiatric services complicated by communication factor Office 2023 67 67 $1,243 $596.12 48.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 27 61 $7,458 $3,752 50.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 28 49 $4,060 $1,896 46.7%

About Michael Billock

Michael Billock is a Psychiatric/Mental Health healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2021. The National Provider Identifier (NPI) number assigned to this provider is 1962164046.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Billock has received a total of $3,673 in payments from pharmaceutical and medical device companies, with $1,127 received in 2024. These payments were reported across 164 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,599).

As a Medicare-enrolled provider, Billock has provided services to 528 Medicare beneficiaries, totaling 823 services with total Medicare billing of $52,607. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Dublin, OH
  • Active Since 10/06/2021
  • Last Updated 03/17/2023
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1962164046

Products in Payments

  • INGREZZA (Drug) $722.38
  • ABILIFY MAINTENA (Drug) $417.93
  • CAPLYTA (Drug) $404.73
  • INVEGA SUSTENNA (Drug) $391.29
  • VRAYLAR (Drug) $346.83
  • REXULTI (Drug) $337.53
  • AUSTEDO (Drug) $273.24
  • NUPLAZID (Drug) $143.68
  • ARISTADA (Drug) $110.30
  • HETLIOZ (Drug) $75.06
  • SECUADO (Drug) $55.48
  • Austedo XR (Drug) $54.07
  • AZSTARYS (Drug) $48.63
  • GRALISE (Drug) $46.35
  • PERSERIS (Drug) $40.72
  • ABILIFY ASIMTUFII (Drug) $35.67
  • BRINTELLIX (Drug) $31.94
  • SPRAVATO (Drug) $21.25
  • UZEDY (Drug) $19.99
  • VYVANSE (Drug) $18.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Dublin